Hollandbio welcomes Worldwide Clinical Trials as new member

Today, we are proud to welcome Worldwide Clinical Trials (Worldwide) as our new member. Worldwide is a global contract research organization (CRO) serving development-stage biopharmaceutical companies. With operations spanning more than 70 countries and a workforce of over 4,000 professionals, Worldwide’s therapeutically dedicated teams bring direct expertise in neuroscience, oncology, rare disease, and internal medicine – delivering flexible service models and global capability through a high-touch, relationship-led approach. Learn more: www.worldwide.com. “

“Worldwide Clinical Trials is proud to join hollandbio, an organization that connects, represents, and supports the Dutch life science sector. The CRO is honored to be part of a dynamic network of 270 companies – from innovative start-ups to established global organizations – advancing health, food, and the biobased economy. “Worldwide has a strong presence in the Netherlands and supports a robust portfolio of Dutch-based sponsors with their clinical development needs,” shared Gijsbert Veerman, Worldwide’sVice President, Early Phase Oncology – Europe. “We look forward to contributing to and collaborating within this vibrant community.”